Self-Study HBV Lessons
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
An entire Cc section, or just a few topics at a time.
3
Take the CE Quiz
5 questions covering the topics in each Cc section.
4
Claim CE Credit
Free CNE and Free CME available!
Section Navigation
Section Navigation
- Lesson 6 Overview
Choosing an Initial HBV Treatment Regimen - 0%Topic 1
BackgroundActivities- 0%Topic 2
Oral Antiviral Therapy Options for HBVActivities- 0%Topic 3
Peginterferon-Based Therapy for HBVActivities- 0%Topic 4
Choosing Oral Antivirals versus PeginterferonChoosing an Initial HBV Treatment Regimen Overview
About this Lesson
Last Updated: February 18th, 2020CNE/CME Continuing Education
This lesson qualifies for:- 1 CME AMA PRA Category 1 Credit™, or
- 1 CNE contact hour and 1 CE contact hour (qualifies for pharmacology CE for advanced practice nurses)
CNE and CME Origination: January 1st, 2020CNE and CME Review: December 1st, 2022CNE and CME Expiration: November 30th, 2025 (2nd Edition)
View CE NoticesSteps to Acquire CE for this Lesson:
1Quiz
Score 80%+2Give Feedback
Complete survey3Print CE Certificate
Obtain proof of CE2nd Edition
This is a substantial revision of the original Lesson. The previous edition was titled Choosing an Initial HBV Treatment Regimen and available until December 1st, 2022.Learning Objectives
- Provide rationale for choosing an oral antiviral or interferon-based therapy to treat chronic HBV infection
- Name the three preferred oral antivirals for initial treatment of chronic HBV infection
- Discuss potential adverse effects with medications used to treat chronic HBV infection
- List situations when interferon-based therapy is contraindicated for treatment of chronic HBV
- Recognize special circumstances that warrant modification of standard treatment options for chronic HBV infection
Lesson Contributors
Authors
H. Nina Kim, MDH. Nina Kim, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonReviewers
David H. Spach, MDDavid H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonLesson Plan
Quick Reference View
A single document for easy access to every topic in the self-study modules.
PDF version also available.
No sign-in required for Quick Reference
- 0%Topic 2
Funded by
Centers for Disease Control and Prevention Cooperative Agreement (CDC-RFA-PS21-2105)
Created at
University of Washington
Part of
IDEA Platform
CME provided byUniversity of Alabama Birmingham
CNE provided byUniversity of Washington School of Nursing
- HBV Medications
- Self-Study Modules CNE/CME
- HBV Epidemiology
- HBV Screening, Testing, and Diagnosis
- HBV Immunizations
- Initial Evaluation of Persons with Chronic Hepatitis B
- When to Initiate HBV Treatment
- Choosing an Initial HBV Treatment Regimen
- Preventing HBV Perinatal Transmission
- Screening for Hepatocellular Carcinoma
- Occupational HBV Postexposure Prophylaxis
- Hepatitis B Reactivation in the Setting of Immunosuppression
Quick Reference
- HBV Epidemiology
- HBV Screening, Testing, and Diagnosis
- HBV Immunizations
- Initial Evaluation of Persons with Chronic Hepatitis B
- When to Initiate HBV Treatment
- Choosing an Initial HBV Treatment Regimen
- Preventing HBV Perinatal Transmission
- Screening for Hepatocellular Carcinoma
- Occupational HBV Postexposure Prophylaxis
- Hepatitis B Reactivation in the Setting of Immunosuppression
- Clinical ChallengesHepatitis B Primary Care Guidance Master Bibliography
Contributors - Tools & Calculators
Copyright © 2023 Hepatitis B Online
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhbvc-master-eeab4a0c-2023-09-22-180703